Real‑World Effectiveness of Once‑Weekly Glucagon‑Like Peptide‑1 Receptor Agonists (OW GLP‑1RAs) in Comparison with Dipeptidyl Peptidase‑4 Inhibitors (DPP‑4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)

Image of Real‑World Effectiveness of Once‑Weekly Glucagon‑Like Peptide‑1 Receptor Agonists (OW GLP‑1RAs) in Comparison with Dipeptidyl Peptidase‑4 Inhibitors (DPP‑4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)

PRODUCT LITERATURE

Real‑World Effectiveness of Once‑Weekly Glucagon‑Like Peptide‑1 Receptor Agonists (OW GLP‑1RAs) in Comparison with Dipeptidyl Peptidase‑4 Inhibitors (DPP‑4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)

The efficacy of once-weekly (OW) glucagon-like peptide-1 receptor agonists (GLP-1RAs) has been estab-
lished in several trials in people with type 2 diabetes mellitus (T2DM); however, real-world evidence on their effectiveness
is limited. This study evaluated the effectiveness of OW GLP-1RA regarding glycemic and weight outcomes, and relative
to DPP-4i in a comparator analysis.

Availability

Location name is not set Location name is not set

Vildi-010

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: TEXTBOOK
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Vildi
Specific Detail Info: -
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment